NEW YORK ( TheStreet) -- Novo Nordisk A/S (NYSE: NVO) hit a new 52-week high Monday as it is currently trading at $157.94, above its previous 52-week high of $156.55 with 3,400 shares traded as of 9:30 a.m. ET. Average volume has been 417,200 shares over the past 30 days. Novo Nordisk A/S has a market cap of $88.16 billion and is part of the health care sector and drugs industry. Shares are up 31.9% year to date as of the close of trading on Friday. Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products in Denmark and internationally. The company operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the average drugs industry P/E ratio of 27.4 and below the S&P 500 P/E ratio of 17.7.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!